Abstract
Objectives
It was the first time to examine the role of maternal polymorphisms of FOLR1 gene and FOLR2 gene, as well as their interactions with maternal folic acid supplementation (FAS), in the risk of ventricular septal defect (VSD).
Methods
A case-control study was conducted with 385 mothers of VSD infants and 652 controls. The exposures of interest were FAS and FOLR1 gene and FOLR2 gene polymorphisms. The logistic regression model was used for accessing the strength of association.
Results
After controlling for the potential confounders, women who did not utilize folic acid had a substantially higher risk of VSD (aOR = 2.25; 95% CI: 1.48 to 3.43), compared to those who did. We also observed genetic polymorphisms of FOLR1 gene at rs2071010 (GA vs. GG: aOR = 0.63, 95%CI: 0.45 to 0.88) and rs11235462 (AA vs. TT: aOR = 0.53, 95%CI: 0.33 to 0.84), as well as FOLR2 gene at rs651646 (AA vs. TT: aOR = 0.46, 95%CI: 0.30 to 0.70), rs2298444 (CC vs. TT: aOR = 0.58, 95%CI: 0.36 to 0.91) and rs514933 (TC vs. TT: aOR = 0.57, 95%CI: 0.41 to 0.78) were associated with a lower risk of VSD. Furthermore, there was a statistically significant interaction between maternal FAS and genetic polymorphisms at rs514933 on the risk of VSD (FDR_P = 0.015).
Conclusions
The maternal genetic polymorphisms of the FOLR1 gene and FOLR2 gene, as well as FAS and their interactions, were shown to be significantly associated with the risk of VSD in offspring.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Zhao L, Chen L, Yang T, Wang T, Zhang S, Chen L, et al. Birth prevalence of congenital heart disease in china, 1980-2019: A systematic review and meta-analysis of 617 studies. Eur J Epidemiol. 2020;35:631–42.
Zhang S, Liu X, Yang T, Wang T, Chen L, Qin J. Association of maternal dietary habits and ADIPOQ gene polymorphisms with the risk of congenital heart defects in offspring: a hospital-based case-control study. Eur J Clin Nutr. 2021. https://doi.org/10.1038/s41430-021-00969-4.
Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics. 2001;68:942–942.
Zhu H, Kartiko S, Finnell RH. Importance of gene-environment interactions in the etiology of selected birth defects. Clin Genet. 2009;75:409–23.
Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451:943–8.
Goldmuntz E, Woyciechowski S, Renstrom D, Lupo PJ, Mitchell LE. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet. 2008;1:126–32.
Rosenquist TH. Folate, homocysteine and the cardiac neural crest. Dev Dyn. 2013;242:201–18.
Taparia S, Gelineau-van Waes J, Rosenquist TH, Finnell RH. Importance of folate-homocysteine homeostasis during early embryonic development. Clin Chem Lab Med. 2007;45:1717–27.
Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79:714–27.
Morikawa Y, Cserjesi P. Cardiac neural crest expression of hand2 regulates outflow and second heart field development. Circ Res. 2008;103:1422–9.
Chin AJ, Saint-Jeannet JP, Lo CW. How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease. Mech Dev. 2012;129:75–97.
Keyte A, Hutson MR. The neural crest in cardiac congenital anomalies. Differentiation. 2012;84:25–40.
Øyen N, Olsen SF, Basit S, Leirgul E, Strøm M, Carstensen L, et al. Association between maternal folic acid supplementation and congenital heart defects in offspring in birth cohorts from denmark and norway. J Am Heart Assoc. 2019;8:e011615.
Findley TO, Tenpenny JC, O’Byrne MR, Morrison AC, Hixson JE, Northrup H, et al. Mutations in folate transporter genes and risk for human myelomeningocele. Am J Med Genet A. 2017;173:2973–84.
Saitsu H. Folate receptors and neural tube closure. Congenit Anom. 2017;57:130–3.
Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, et al. Mice lacking the folic acid-binding protein folbp1 are defective in early embryonic development. Nat Genet. 1999;23:228–32.
Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, et al. Structural basis for molecular recognition of folic acid by folate receptors. Nature. 2013;500:486–9.
Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, et al. Embryonic development of folate binding protein-1 (folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn. 2004;231:221–31.
Saitsu H, Ishibashi M, Nakano H, Shiota K. Spatial and temporal expression of folate-binding protein 1 (fbp1) is closely associated with anterior neural tube closure in mice. Dev Dyn. 2003;226:112–7.
O’Leary VB, Mills JL, Kirke PN, Parle-McDermott A, Swanson DA, Weiler A, et al. Analysis of the human folate receptor beta gene for an association with neural tube defects. Mol Genet Metab. 2003;79:129–33.
Boot MJ, Steegers-Theunissen RP, Poelmann RE, Van Iperen L, Lindemans J. Gittenberger-de Groot AC. Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro. Dev Dyn. 2003;227:301–8.
Rosenquist TH, Chaudoin T, Finnell RH, Bennett GD. High-affinity folate receptor in cardiac neural crest migration: A gene knockdown model using sirna. Dev Dyn. 2010;239:1136–44.
Zhu H, Wlodarczyk BJ, Scott M, Yu W, Merriweather M, Gelineau-van Waes J, et al. Cardiovascular abnormalities in folr1 knockout mice and folate rescue. Birth Defects Res A Clin Mol Teratol. 2007;79:257–68.
Zhu H, Cabrera RM, Wlodarczyk BJ, Bozinov D, Wang D, Schwartz RJ, et al. Differentially expressed genes in embryonic cardiac tissues of mice lacking folr1 gene activity. BMC Dev Biol. 2007;7:128.
Antony AC. In utero physiology: Role of folic acid in nutrient delivery and fetal development. Am J Clin Nutr. 2007;85:598s–603s.
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect. 2006;114:1547–52.
O’Byrne MR, Au KS, Morrison AC, Lin JI, Fletcher JM, Ostermaier KK, et al. Association of folate receptor (folr1, folr2, folr3) and reduced folate carrier (slc19a1) genes with meningomyelocele. Birth Defects Res A Clin Mol Teratol. 2010;88:689–94.
Qu Y, Lin S, Zhuang J, Bloom MS, Smith M, Nie Z, et al. First-trimester maternal folic acid supplementation reduced risks of severe and most congenital heart diseases in offspring: a large case-control study. J Am Heart Assoc. 2020;9:e015652.
Leirgul E, Gildestad T, Nilsen RM, Fomina T, Brodwall K, Greve G, et al. Periconceptional folic acid supplementation and infant risk of congenital heart defects in norway 1999-2009. Paediatr Perinat Epidemiol. 2015;29:391–400.
Li Y, Diao J, Li J, Luo L, Zhao L, Zhang S, et al. Association of maternal dietary intakes and cbs gene polymorphisms with congenital heart disease in offspring. Int J Cardiol. 2021;322:121–8.
Zheng G, Ng HKT. Genetic model selection in two-phase analysis for case-control association studies. Biostatistics. 2008;9:391–9.
Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.
Shaw GM, O’Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;59:536–45.
Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ. 1993;306:1645–8.
Csáky-Szunyogh M, Vereczkey A, Kósa Z, Gerencsér B, Czeizel AE. Risk and protective factors in the origin of conotruncal defects of heart-a population-based case-control study. Am J Med Genet A. 2013;161a:2444–52.
Jiang S, Wang J, Duan Y, Pang X, Bi Y, Zhang H, et al. Folic acid status and associated factors for pregnant chinese women - china, 2015. China CDC Wkly. 2021;3:226–31.
Li X, Li S, Mu D, Liu Z, Li Y, Lin Y, et al. The association between periconceptional folic acid supplementation and congenital heart defects: A case-control study in china. Prev Med. 2013;56:385–9.
Wang D, Jin L, Zhang J, Meng W, Ren A, Jin L. Maternal periconceptional folic acid supplementation and risk for fetal congenital heart defects. J Pediatr. 2022;240:72–78.
Mao B, Qiu J, Zhao N, Shao Y, Dai W, He X, et al. Maternal folic acid supplementation and dietary folate intake and congenital heart defects. PLoS One. 2017;12:e0187996.
Xu A, Cao X, Lu Y, Li H, Zhu Q, Chen X, et al. A meta-analysis of the relationship between maternal folic acid supplementation and the risk of congenital heart defects. Int Heart J. 2016;57:725–8.
Shaw GM, Lu W, Zhu H, Yang W, Briggs FB, Carmichael SL, et al. 118 snps of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet. 2009;10:49.
RP K, T S, B S, T MK, A J. Lrp2 gene variants and their haplotypes strongly influence the risk of developing neural tube defects in the fetus: A family-triad study from south india. Metab Brain Dis. 2018;33:1343–52.
Solanky N, Requena Jimenez A, D’Souza SW, Sibley CP, Glazier JD. Expression of folate transporters in human placenta and implications for homocysteine metabolism. Placenta. 2010;31:134–43.
Prasad PD, Ramamoorthy S, Moe AJ, Smith CH, Leibach FH, Ganapathy V. Selective expression of the high-affinity isoform of the folate receptor (fr-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta. 1994;1223:71–75.
Acknowledgements
We would like to thank the editors and reviewers for their suggestions and all colleagues working in Maternal and Child Health Promotion and Birth Defect Prevention Group.
Funding
This study was supported by the Project Funded by National Natural Science Foundation Program of China (82073653 and 81803313), Hunan Provincial Key Research and Development Program (2018SK2063 and 2018SK2062), Hunan Provincial Science and Technology Talent Support Project (2020TJ-N07), Natural Science Foundation of Hunan Province (2018JJ2551), Open Project from NHC Key Laboratory of Birth Defect for Research and Prevention (KF2020006), and The 68th General Program Supported by China Postdoctoral Science Foundation (2020M682644).
Author information
Authors and Affiliations
Contributions
Conceived and designed the experiments: PZ, JBQ, XLS and JHW. Performed the experiments: MTS and YPL. Analyzed the data and statistical analyses: JS and MTS. Contributed reagents/material/analysis tools: JS, YPL and MTS. Wrote the main manuscript text: XLS and PZ. Reference collection and data management: JBQ and XLS. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Song, X., Wei, J., Shu, J. et al. Association of polymorphisms of FOLR1 gene and FOLR2 gene and maternal folic acid supplementation with risk of ventricular septal defect: a case-control study. Eur J Clin Nutr 76, 1273–1280 (2022). https://doi.org/10.1038/s41430-022-01110-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-022-01110-9